マーケットレポート詳細
家畜用ワクチンの世界市場：2031年予測
Livestock Vaccines Market (Vaccine Type: Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, and Others; and Technology: Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
- 出版元：Transparency Market Research
出版元について - 発行年：2023年11月
- 定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文165ページになります。
- 商品コード：TMR122
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
家畜用ワクチンの世界市場規模は2022年で54億ドル、2031年に94億ドル、市場の平均年成長率は6.4%になる見込みです。
当レポートでは、家畜用ワクチンの市場予測-2031年、各種セグメント別市場分析(タイプ別、技術別、国地域別、等)、市場ダイナミクス、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
■家畜用ワクチンの世界市場予測2023-2031年
・市場規模(US$)
■タイプ別、市場-2031年
牛用ワクチン
家禽ワクチン
豚ワクチン
その他
※(市場規模US$)
■技術別、市場-2031年
生ワクチン
不活化ワクチン
組換ワクチン
その他
※(市場規模US$)
■投与経路別、市場-2031年
経口
非経口
その他
※(市場規模US$)
■エンドユーザー別、市場-2031年
動物病院
動物クリニック
その他
※(市場規模US$)
■主要国地域別市場-2031年
北米
・米国、カナダ
・その他北米
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア・ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
■市場分析
市場ダイナミクス（促進要因、障壁、機会）
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析
■家畜用ワクチンの主要企業プロフィール動向
Dechra Pharmaceuticals PLC
Ceva Santé Animale
Elanco
Merck & Co., Inc.
Zoetis Services LLC
Boehringer Ingelheim International GmbH.
Virbac
Biogénesis Bagó
Ourofino Saúde Animal
VETAL Animal Health Products, Inc.
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Livestock Vaccines Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Livestock Vaccines Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Disease Epidemiology
5.2. Pipeline Analysis
5.3. Key Industry Events
5.4. COVID-19 Pandemic Impact on Industry
6. Global Livestock Vaccines Market Analysis and Forecast, by Vaccine Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Vaccine Type, 2023–2031
6.3.1. Bovine Vaccine
6.3.2. Poultry Vaccine
6.3.3. Porcine Vaccine
6.3.4. Others
6.4. Market Attractiveness Analysis, by Vaccine Type
7. Global Livestock Vaccines Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2023–2031
7.3.1. Live Attenuated Vaccine
7.3.2. Inactivated Vaccine
7.3.3. Recombinant Vaccine
7.3.4. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Livestock Vaccines Market Analysis and Forecasts, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Route of Administration, 2023–2031
8.3.1. Oral
8.3.2. Parenteral
8.3.3. Others
8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Livestock Vaccines Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2023–2031
9.3.1. Veterinary Hospitals
9.3.2. Veterinary Clinics
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Livestock Vaccines Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2023–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Livestock Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Vaccine Type, 2023–2031
11.2.1. Bovine Vaccine
11.2.2. Poultry Vaccine
11.2.3. Poultry Vaccine
11.2.4. Others
11.3. Market Value Forecast, by Technology, 2023–2031
11.3.1. Live Attenuated Vaccine
11.3.2. Inactivated Vaccine
11.3.3. Recombinant Vaccine
11.3.4. Others
11.4. Market Value Forecast, by Route of Administration, 2023–2031
11.4.1. Oral
11.4.2. Parenteral
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2023–2031
11.5.1. Veterinary Hospitals
11.5.2. Veterinary Clinics
11.5.3. Others
11.6. Market Value Forecast, by Country, 2023–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Vaccine Type
11.7.2. By Technology
11.7.3. By Route of Administration
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Livestock Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Vaccine Type, 2023–2031
12.2.1. Bovine Vaccine
12.2.2. Poultry Vaccine
12.2.3. Porcine Vaccine
12.2.4. Others
12.3. Market Value Forecast, by Technology, 2023–2031
12.3.1. Live Attenuated Vaccine
12.3.2. Inactivated Vaccine
12.3.3. Recombinant Vaccine
12.3.4. Others
12.4. Market Value Forecast, by Route of Administration, 2023–2031
12.4.1. Oral
12.4.2. Parenteral
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2023–2031
12.5.1. Veterinary Hospitals
12.5.2. Veterinary Clinics
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2023–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Vaccine Type
12.7.2. By Technology
12.7.3. By Route of Administration
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Livestock Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Vaccine Type, 2023–2031
13.2.1. Bovine Vaccine
13.2.2. Poultry Vaccine
13.2.3. Porcine Vaccine
13.2.4. others
13.3. Market Value Forecast, by Technology, 2023–2031
13.3.1. Live Attenuated Vaccine
13.3.2. Inactivated Vaccine
13.3.3. Recombinant Vaccine
13.3.4. Others
13.4. Market Value Forecast, by Route of Administration, 2023–2031
13.4.1. Oral
13.4.2. Parenteral
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2023–2031
13.5.1. Veterinary Hospitals
13.5.2. Veterinary Clinics
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2023–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Vaccine Type
13.7.2. By Technology
13.7.3. By Route of Administration
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Livestock Vaccines Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Vaccine Type, 2023–2031
14.2.1. Bovine Vaccine
14.2.2. Poultry Vaccine
14.2.3. Porcine Vaccine
14.2.4. Others Vaccine
14.3. Market Value Forecast, by Technology, 2023–2031
14.3.1. Live Attenuated Vaccine
14.3.2. Inactivated Vaccine
14.3.3. Recombinant Vaccine
14.3.4. Others
14.4. Market Value Forecast, by Route of Administration, 2023–2031
14.4.1. Oral
14.4.2. Parenteral
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2023–2031
14.5.1. Veterinary Hospitals
14.5.2. Veterinary Clinics
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2023–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Vaccine Type
14.7.2. By Technology
14.7.3. By Route of Administration
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Livestock Vaccines Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Vaccine Type, 2023–2031
15.2.1. Bovine Vaccine
15.2.2. Poultry Vaccine
15.2.3. Porcine Vaccine
15.2.4. Others
15.3. Market Value Forecast, by Technology, 2023–2031
15.3.1. Live Attenuated Vaccine
15.3.2. Inactivated Vaccine
15.3.3. Recombinant Vaccine
15.3.4. Others
15.4. Market Value Forecast, by Route of Administration, 2023–2031
15.4.1. Oral
15.4.2. Parenteral
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2023–2031
15.5.1. Veterinary Hospitals
15.5.2. Veterinary Clinics
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2023–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Vaccine Type
15.7.2. By Technology
15.7.3. By Route of Administration
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Dechra Pharmaceuticals PLC
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Ceva Santé Animale
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Elanco
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Merck & Co., Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Zoetis Services LLC
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Boehringer Ingelheim International GmbH.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Virbac
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Biogénesis Bagó
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Ourofino Saúde Animal
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. VETAL Animal Health Products, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Other prominent Players
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
List of Tables
Table 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 02: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 03: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 04: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 05: Global Livestock Vaccines Market Value (US$ Mn) Forecast, by Region, 2023–2031
Table 06: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country, 2023–2031
Table 07: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 08: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 09: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 10: North America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 11: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 12: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 13: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 14: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 15: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 16: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 17: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 18: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 19: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 20: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 21: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 22: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 23: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 24: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 25: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
Table 26: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 27: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Vaccine Type, 2023–2031
Table 28: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Technology, 2023‒2031
Table 29: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2023–2031
Table 30: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, by End-user, 2023–2031
List of Figures
Figure 01: Global Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 02: Global Livestock Vaccines Market Value Share, by Vaccine Type, 2022
Figure 03: Livestock Vaccines Market Value Share, by Technology, 2022
Figure 04: Livestock Vaccines Market Value Share, by Route of Administration, 2022
Figure 05: Global Livestock Vaccines Market Value Share, by End-user, 2022
Figure 06: Global Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 07: Global Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 08: Global Livestock Vaccines Market Revenue (US$ Mn), by Bovine Vaccine , 2023–2031
Figure 09: Global Livestock Vaccines Market Revenue (US$ Mn), by Poultry Vaccine, 2023–2031
Figure 10: Global Livestock Vaccines Market Revenue (US$ Mn), by Porcine Vaccine, 2023–2031
Figure 11: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023–2031
Figure 12: Global Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 13: Global Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 14: Global Livestock Vaccines Market Value (US$ Mn), by Live Attenuated Vaccine, 2023‒2031
Figure 15: Global Livestock Vaccines Market Value (US$ Mn), by Inactivated Vaccine, 2023‒2031
Figure 16: Global Livestock Vaccines Market Value (US$ Mn), by Recombinant Vaccine, 2023‒2031
Figure 17: Global Livestock Vaccines Market Value (US$ Mn), by Others, 2023‒2031
Figure 18: Global Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 19: Global Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 20: Global Livestock Vaccines Market Revenue (US$ Mn), by Oral , 2023–2031
Figure 21: Global Livestock Vaccines Market Revenue (US$ Mn), by Parenteral, 2023–2031
Figure 22: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023–2031
Figure 23: Global Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: Global Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 25: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Hospitals, 2023–2031
Figure 26: Global Livestock Vaccines Market Revenue (US$ Mn), by Veterinary Clinics, 2023–2031
Figure 27: Global Livestock Vaccines Market Revenue (US$ Mn), by Others, 2023–2031
Figure 28: Global Livestock Vaccines Market Value Share Analysis, by Region, 2022 and 2031
Figure 29: Global Livestock Vaccines Market Attractiveness Analysis, by Region, 2023–2031
Figure 30: North America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 31: North America Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
Figure 32: North America Livestock Vaccines Market Attractiveness Analysis, by Country, 2023–2031
Figure 33: North America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 34: North America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 35: North America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 36: North America Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 37: North America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 38: North America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 39: North America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: North America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 41: Europe Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 42: Europe Livestock Vaccines Market Value Share Analysis, by Country, 2022 and 2031
Figure 43: Europe Livestock Vaccines Market Attractiveness Analysis, by Country, 2023–2031
Figure 44: Europe Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 45: Europe Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 46: Europe Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 47: Europe Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 48: Europe Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 49: Europe Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 50: Europe Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Europe Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 52: Asia Pacific Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 53: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 54: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 55: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 56: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 57: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 58: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 59: Asia Pacific Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 60: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 61: Asia Pacific Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Asia Pacific Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 63: Latin America Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 64: Latin America Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 65: Latin America Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 66: Latin America Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 67: Latin America Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 68: Latin America Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 69: Latin America Livestock Vaccines Market Attractiveness Analysis, by Technology, 2023–2031
Figure 70: Latin America Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 71: Latin America Livestock Vaccines Market Attractiveness Analysis, Route of Administration, 2023–2031
Figure 72: Latin America Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Latin America Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 74: Middle East & Africa Livestock Vaccines Market Value (US$ Mn) Forecast, 2023–2031
Figure 75: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 76: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 77: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Vaccine Type, 2022 and 2031
Figure 78: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Vaccine Type, 2023–2031
Figure 79: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Technology, 2022 and 2031
Figure 80: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Technology 2023–2031
Figure 81: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by Route of Administration, 2022 and 2031
Figure 82: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by Route of Administration, 2023–2031
Figure 83: Middle East & Africa Livestock Vaccines Market Value Share Analysis, by End-user, 2022 and 2031
Figure 84: Middle East & Africa Livestock Vaccines Market Attractiveness Analysis, by End-user, 2023–2031
Figure 85: Global Livestock Vaccines Market Share Analysis By Company (2022)